CymaBay Therapeutics to Present at the SVB Securities Global Biopharma Conference
Provided By Globe Newswire
Last update: Feb 6, 2023
NEWARK, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that management will participate in the SVB Securities Global Biopharma Conference.
